Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS

Immunopharmacology

Volumn 40, Issue 2, 1998, Pages 91-103

  Pan, George ^a   Zhou, Tong ^b   Radding, Wilson ^a   Saag, Michael S ^b   Mountz, John D ^b,c   McDonald, Jay M ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

AIDS; Apoptosis; Calmodulin; Tamoxifen; Trifluoperazine

Indexed keywords

CALMODULIN; CALMODULIN INHIBITOR; DNA FRAGMENT; FAS LIGAND; TAMOXIFEN; TRIFLUOPERAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APOPTOSIS; CALMODULIN; CD4-POSITIVE T-LYMPHOCYTES; DNA; DOPAMINE ANTAGONISTS; ESTROGEN ANTAGONISTS; HUMANS; LEUKOCYTES, MONONUCLEAR; TAMOXIFEN; TRIFLUOPERAZINE;

EID: 0031755556     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00018-6     Document Type: Article

References (58)

1. Amendola A., Lombardi G., Oliverio S., Colizzi V., Piacentini M. HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T-cell clones is characterized by 'tissue' transglutaminase expression and prevented by cyclosporin A. FEBS Lett. 339:1994;258-264.
2. Badley A.D., McElhinny J.A., Leibson P.J., Lynch D.H., Alderson M.R., Paya C.V. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:1996;199-206.
3. Banda N.K., Bernier J., Kurahara D.K., Kurrle R., Haigwood N., Sekaly R.P., Finkel T.H. Crosslinking CD4 by human immunodeficiency virus gp120 primes T-cells for activation-induced apoptosis. J. Exp. Med. 176:1992;1099-1106.
4. Baumler C.B., Bohler T., Herr I., Benner A., Krammer P.H., Debatin K.M. Activation of the CD95 (APO-1/Fas) system in T-cells from human immunodeficiency virus type-1-infected children. Blood. 88:1996;1741-1746.
5. + T lymphocytes during HIV infection. J. Immunol. 156:1996;2282-2293.
6. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F., Green D.R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441-444.
7. + T-cells during an immune response to HIV-1-pulsed dendritic cells. AIDS Res. Hum. Retroviruses. 10:1994;61-71.
8. CDC Extension of public comment period for revision of HIV infection classification system and expansion of AIDS surveillance case definition. Morb. Mortal Wkly. Rep. 40:1992;891-892.
9. Cohen J.J., Duke R.C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:1984;38-42.
10. Corbeil J., Tremblay M., Richman D.D. HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck. J. Exp. Med. 183:1996;39-48.
11. + T-cell deletion after specific activation in HIV-infected individuals; protection by anti-CD28 monoclonal antibodies. Clin. Exp. Immunol. 105:1996;31-38.
12. Dowd D.R., MacDonald P.N., Komm B.S., Haussler M.R., Miesfeld R. Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis. J. Biol. Chem. 266:1991;18423-18426.
13. + T-cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1995;1759-1767.
14. + T-cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:1996;4959-4966.
15. Fleck, M., Zhou, T., Tatsuta, T., Yang, P., Wang, Z., Mountz, J.D., 1998. Detection of apoptotic cells at an early stage by 7-amino-actinomycin D and comparison with other methods. (Submitted).
16. Foster S., Beverley P., Aspinall R. gp120-induced programmed cell death in recently activated T-cells without subsequent ligation of the T-cell receptor. Eur. J. Immunol. 25:1995;1778-1782.
17. Gougeon M.L., Laurent-Crawford A.G., Hovanessian A.G., Montagnier L. Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T-cell depletion. Semin. Immunol. 5:1993;187-194.
18. Gougeon M.L. Chronic activation of the immune system in HIV infection: Contribution to T-cell apoptosis and Vβ selective T-cell anergy. Curr. Top. Microbiol. Immunol. 200:1995;177-193.
19. Gougeon M.L., Lecoeur H., Dulioust A., Enouf M.G., Crouvoiser M., Goujard C., Debord T., Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T-cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:1996;3509-3520.
20. + T-cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:1992;331-340.
21. Han X., Becker K., Degen H.J., Jablonowski H., Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur. J. Clin. Invest. 26:1996;286-292.
22. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.-I., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediated apoptosis. Cell. 66:1991;233-243.
23. Ju S.T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothsetin A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444-446.
24. Katsikis P.D., Wunderlich E.S., Smith C.A., Herzenberg L.A., Herzenberg L.A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:1995;2029-2036.
25. Kornbluth R.S. Significance of T-cell apoptosis for macrophages in HIV infection. J. Leukocyte Biol. 56:1994;247-256.
26. Laurence J., Cooke H., Sikder S.K. Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. Blood. 75:1990;696-703.
27. Laurent-Crawford A.G., Krust B., Rivière Y., Desgranges C., Muller S., Kieny M.P., Dauguet C., Hovanessian A.G. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses. 9:1993;761-773.
28. + target cells. Res. Virol. 146:1995;5-17.
29. Li C.J., Friedman D.J., Wang C., Metelev V., Pardee A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 268:1995;429-431.
30. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.
31. McCloskey T.W., Oyaizu N., Kaplan M., Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry. 22:1995;111-114.
32. McConkey D.J., Jondal M., Orrenius S. Cellular signaling in thymocyte apoptosis. Semin. Immunol. 4:1992;371-377.
33. McConkey D.J., Orrenius S. Calcium and cyclosporin A in the regulation of apoptosis. Curr. Top. Microbiol. Immunol. 200:1995;95-105.
34. Mesange F., Delarue F., Puel J., Bayard F., Faye J.-C. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes. Mol. Pharmacol. 50:1996;75-79.
35. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P.M., Miedema F. Programmed death of T-cells in HIV-1 infection. Science. 257:1992;217-219.
36. + T-cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology. 87:1996;581-585.
37. Muro-Cacho C.A., Pantaleo G., Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566.
38. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449-1456.
39. + T lymphocytes is not mediated by Fas-Fas ligand. AIDS. 11:1997;1671-1680.
40. Oyaizu N., McCloskey T.W., Coronesi M., Chirmule N., Kalyanaraman V.S., Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus Type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82:1993;3392-3400.
41. Oyaizu N., Pahwa S. Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15:1995;217-231.
42. Pan Z.G., Radding W., Zhou T., Hunter E., Mountz J., McDonald J.M. Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. Am. J. Pathol. 149:1996;903-910.
43. Pandolfi F., Pierdominici M., Oliva A., D'Offizi G., Mezzaroma I., Mollicone B., Giovannetti A., Rainaldi L., Quinti I., Aiuti F. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 9:1995;450-458.
44. Pantaleo G., Fauci A.S. Apoptosis in HIV infection. Nature Med. 1:1995;118-120.
45. Purvis S.F., Jacobberger J.W., Sramkoski R.M., Patki A.H., Lederman M.M. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses. 11:1995;443-450.
46. Radding W., Pan Z.Q., Hunter E., Johnston P., Williams J.P., McDonald J.M. Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. Biochem. Biophys. Res. Commun. 218:1996;192-197.
47. Rossio J.L., Bess J. Jr., Henderson L.E., Cresswell P., Arthur L.O. HLA class II on HIV particles is functional in superantigen presentation to human T-cells: implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses. 11:1995;1433-1439.
48. + donors by cysteine protease inhibitors. J. Immunol. 153:1994;862-872.
49. Schmid I., Uittenbogaart C.H., Keld B., Giorgi J.V. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods. 170:1994;145-157.
50. Schmid I., Uittenbogaart C.H., Giorgi J.V. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry. 15:1994;12-20.
51. Schwartzman R.A., Cidlowski J.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:1993;133-151.
52. Sekigawa I., Koshino K., Hishikawa T., Kaneko H., Takasaki Y., Hashimoto H., Hirose S., Inagaki Y., Yamamoto N. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. J. Clin. Immunol. 15:1995;312-317.
53. Strack P.R., Frey M.W., Rizzo C.J., Cordova B., George H.J., Meade R., Ho S.P., Corman J., Tritch R., Korant B.D. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9571-9576.
54. Szawlowski P.W., Hanke T., Randall R.E. Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas. AIDS. 7:1993;1018. [letter].
55. Thomson A.W., Bonham C.A. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. Adv. Exp. Med. Biol. 374:1995;211-216.
56. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T-cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
57. Zagury J.F., Cantalloube H., Achour A., Cho Y.Y., Fall L., Lachgar A., Chams V., Astgen A., Biou D., Picard O. Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS. Biomed. Pharmacother. 47:1993;331-335.
58. Zhou T., Fleck M., Müeller-Ladner U., Yang P., Wang Z., Gay S., Matsumoto S., Mountz J.D. Kinetics of Fas-induced apoptosis in thymic organ culture. J. Clin. Immunol. 17:1997;74-84.